February 9, 2015
Daily, oral pre-exposure prophylaxis (PrEP) using the antiretroviral drugs tenofovir and emtricitabine has been approved by the US FDA since 2012, but not a lot of people know about it. Those who do may be most familiar with more practical aspects, like where to get it and whether it’s covered by insurance, than what PrEP actually does in the body.
This newly released video from the PrEP Audio Visual Representation (PrEP REP) project animates how PrEP protects against HIV and reinforces why adherence is so important.